Influenza, SARS-CoV-2 and RSV activity in EU/EEA Member States continue to decrease or remain stable at low levels. Cases, including severe infections, can still occur and it therefore remains essential to continue testing patients presenting with severe acute respiratory symptoms in order to guide treatment and inform epidemiological assessments.
Influenza, SARS-CoV-2 and RSV activity in EU/EEA Member States continue to decrease or remain stable at low levels. Cases, including severe infections, can still occur and it therefore remains essential to continue testing patients presenting with severe acute respiratory symptoms in order to guide treatment and inform epidemiological assessments.
Influenza, SARS-CoV-2 and RSV activity in EU/EEA Member States continue to decrease or remain stable at low levels. Cases, including severe infections, can still occur and it therefore remains essential to continue testing patients presenting with severe acute respiratory symptoms in order to guide treatment and inform epidemiological assessments.
The Global Influenza Surveillance and Response System (GISRS), led by WHO, is used for the international virological and epidemiological surveillance of human influenza.
The clinical surveillance of influenza in the European Influenza Surveillance Network (EISN) is generally based on reports made by sentinel general practitioners. Some of the sentinel surveillance systems also include paediatricians and physicians with other specialisations. The physicians usually represent 1-5% of physicians working in the country or region.
There are general objectives for integrated surveillance of respiratory viruses in the European Union. These objectives apply to surveillance of influenza, COVID-19, and other respiratory virus infections.